Cirtran CORP (CIRX) — SEC Filings

Q: What are the key financial highlights for Cirtran CORP?

Key financial highlights for Cirtran CORP are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Cirtran CORP?

Key executives at Cirtran CORP are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Cirtran CORP stock?

Risk factors for Cirtran CORP (CIRX) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Cirtran CORP?

Forward-looking statements and predictions from Cirtran CORP are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Cirtran CORP. Recent 8-K filing on Dec 29, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Cirtran CORP on SEC EDGAR

Overview

Cirtran CORP (CIRX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 29, 2025: On December 22, 2025, CirTran Corporation entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement, its counterparty, or any associated financial figures. The report was filed on December 29, 2025.

Sentiment Summary

Across 9 filings, the sentiment breakdown is: 1 bearish, 8 neutral. The dominant filing sentiment for Cirtran CORP is neutral.

Filing Type Overview

Cirtran CORP (CIRX) has filed 1 8-K, 6 10-Q, 2 10-K with the SEC between Apr 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (9)

CirTran Corp Files Material Definitive Agreement — 8-K · Dec 29, 2025 Risk: medium
On December 22, 2025, CirTran Corporation entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement, its co
CirTran Narrows Losses, Boosts Sales Amidst Rising Related-Party Debt — 10-Q · Nov 20, 2025 Risk: high
CIRTRAN CORP reported a net loss of $1,138,064 for the nine months ended September 30, 2025, a significant improvement from the $1,814,150 net loss in the prior
CIRTRAN CORP Files Q2 2025 10-Q — 10-Q · Aug 19, 2025 Risk: medium
CIRTRAN CORP filed its 10-Q for the period ending June 30, 2025, reporting on its financial performance. The company, formerly known as VERMILLION VENTURES INC,
Cirtran Corp Files 10-Q for Q1 2025 — 10-Q · May 20, 2025 Risk: low
Cirtran Corp filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Vermillion Ventures Inc., is incorporated in Nevada and operate
Cirtran Corp. Files 2024 10-K — 10-K · Apr 15, 2025 Risk: low
Cirtran Corp. filed its 2024 10-K on April 15, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Vermillion Ventures Inc., is i
Cirtran Corp. Files Q3 2024 10-Q — 10-Q · Nov 14, 2024 Risk: low
Cirtran Corp. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Vermillion Ventures Inc., is incorporated in Nevada and op
Cirtran Corp. Files Q2 2024 10-Q — 10-Q · Aug 26, 2024 Risk: low
Cirtran Corp. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The filing details its financial position, including a
CIRTRAN CORP Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024 Risk: low
CIRTRAN CORP (CIRX) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. CIRTRAN CORP filed a 10-Q report for the period ending March 31, 2024. The fil
CIRTRAN CORP Files 2023 Annual Report on Form 10-K — 10-K · Apr 19, 2024 Risk: low
CIRTRAN CORP (CIRX) filed a Annual Report (10-K) with the SEC on April 19, 2024. CIRTRAN CORP filed its annual report for the fiscal year ended December 31, 202

Risk Profile

Risk Assessment: Of CIRX's 9 recent filings, 1 were flagged as high-risk, 2 as medium-risk, and 6 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Cirtran CORP's most recent 10-Q filing (Nov 20, 2025):

Revenue: $1,077,743
Net Income: -$1,138,064
EPS: N/A
Debt-to-Equity: N/A
Cash Position: $19,274
Operating Margin: -86.85%
Total Assets: N/A
Total Debt: $27,460,669

Key Executives

Iehab Hawatmeh

Industry Context

CIRTRAN CORP operates in the contract manufacturing sector. This industry is characterized by intense competition, price sensitivity, and the need for efficient operations to maintain profitability. Companies often face challenges related to supply chain management, technological advancements, and fluctuating demand from their clients.

Top Tags

10-Q (5) · SEC Filing (3) · financials (3) · reporting (2) · quarterly-report (2) · 10-K (2) · CIRTRAN CORP (2) · material-definitive-agreement (1) · contract (1) · Penny Stock (1)

Key Numbers

Net Loss: $1,138,064 — for the nine months ended September 30, 2025, a 37.2% improvement from $1,814,150 in 2024
Net Sales: $1,077,743 — for the nine months ended September 30, 2025, a slight increase from $1,075,952 in 2024
Gross Profit: $533,062 — for the nine months ended September 30, 2025, a decrease from $619,419 in 2024
Total Liabilities: $27,460,669 — as of September 30, 2025, an increase from $25,937,893 at December 31, 2024
Short-term advances payable - related parties: $1,104,000 — as of September 30, 2025, a significant increase from $22,452 at December 31, 2024
Cash: $19,274 — as of September 30, 2025, up from $0 at December 31, 2024
Accumulated Deficit: $62,782,131 — as of September 30, 2025, an increase from $61,644,067 at December 31, 2024
Proceeds from related-party loans: $1,081,448 — for the nine months ended September 30, 2025, a primary source of cash
Derivative liability: $2,492,987 — as of September 30, 2025, a Level 3 fair value measurement
Common shares outstanding: 4,945,417 — as of November 19, 2025
Period End Date: 20250630 — Indicates the end of the reporting quarter
Filing Date: 20250819 — Shows when the report was submitted to the SEC
Fiscal Year End: 20241231 — The reporting period concluded on this date.
Reporting Period End: 2024-09-30 — Latest quarterly financial data
Prior Year Period End: 2023-09-30 — Comparison for year-over-year performance

Frequently Asked Questions

What are the latest SEC filings for Cirtran CORP (CIRX)?

Cirtran CORP has 9 recent SEC filings from Apr 2024 to Dec 2025, including 6 10-Q, 2 10-K, 1 8-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of CIRX filings?

Across 9 filings, the sentiment breakdown is: 1 bearish, 8 neutral. The dominant sentiment is neutral.

Where can I find Cirtran CORP SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Cirtran CORP (CIRX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Cirtran CORP?

Key financial highlights from Cirtran CORP's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for CIRX?

The investment thesis for CIRX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Cirtran CORP?

Key executives identified across Cirtran CORP's filings include Iehab Hawatmeh.

What are the main risk factors for Cirtran CORP stock?

Of CIRX's 9 assessed filings, 1 were flagged high-risk, 2 medium-risk, and 6 low-risk.

What are recent predictions and forward guidance from Cirtran CORP?

Forward guidance and predictions for Cirtran CORP are extracted from SEC filings as they are enriched.